Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.
For example, knowing that 40% of the children with atopic dermatitis will subsequently develop asthma, the Early Treatment of Atopic Child (ETAC) study was a randomized controlled trial of ...
GSK's new long-acting drug candidate for severe ... said that the drug had achieved the "fundamental treatment goal in asthma" by slashing asthma attacks and hospitalisations.